Investor relations
Nordhealth is a company listed on Euronext Growth as NORDH
Investor presentation
A brief overview of the company and recent history.
- Watch Q3/2021 investor presentation recordingNovember 30, 2021
- Download Q3/2021 presentationNovember 30, 2021
- Watch H1/2021 investor presentation recordingSeptember 30, 2021
- Download H1/2021 presentationSeptember 30, 2021
- Download Nordhealth introductionJune 3, 2021
Financial reports
Admission document
The attached information document has been prepared by Nordhealth solely for use in connection with the admission to trading of the Company’s class A shares on Euronext Growth Oslo, commencing on 3 June 2021.
Stock exchange releases
Get the latest stock exchange releases directly from our news platform.
- Nordhealth continues strategic growth, adds animal health industry expertsJanuary 25, 2022
- Nordhealth AS: Q3/2021 Financial report and presentationNovember 30, 2021
- Nordhealth - Invitation to Q3 2021 presentationNovember 25, 2021
- Nordhealth chooses Nets Group as payments provider in NordicsOctober 29, 2021
- Nordhealth appoints new Chief Financial Officer, as current CFO transitions to CEO of Nordhealth’s veterinary business unitOctober 14, 2021
- Nordhealth AS: H1/2021 Financial report and presentationSeptember 30, 2021
- Nordhealth - Invitation to Q2 2021 presentationSeptember 27, 2021
- Nordhealth AS: Primary insider noticesJuly 5, 2021
- Nordhealth AS – End of stabilization and partial exercise of greenshoe optionJuly 3, 2021
- Nordhealth AS – Stabilization measures takenJune 11, 2021